Estrella Immunopharma, Inc. (ESLA) News
Follow Estrella Immunopharma, Inc. (ESLA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Estrella Immunopharma treats first patient in STARLIGHT-1 dose-expansion phase
The patient received two EB103 infusions.
EQUITY | Oct 15, 2026, 10:46 PM UTC
M
Estrella Immunopharma Activates Oregon Site
Estrella Immunopharma starts new clinical trial site
EQUITY | Aug 03, 2026, 12:04 PM UTC
H
Estrella Activates 2nd Site for Lymphoma Trial
Estrella starts second trial site
EQUITY | Jul 29, 2026, 12:03 PM UTC